Literature DB >> 2652317

Pharmacokinetics and metabolism of Navelbine.

A Krikorian1, R Rahmani, M Bromet, P Bore, J P Cano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2652317

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  14 in total

1.  Antiproliferative activity of vinorelbine (Navelbine) against six human melanoma cell lines.

Authors:  A Photiou; M N Sheikh; D Bafaloukos; S Retsas
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 2.  Clinical pharmacokinetics of vinorelbine.

Authors:  D Levêque; F Jehl
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

Review 3.  New oral chemotherapeutic agents for lung cancer.

Authors:  E M Bengtson; J R Rigas
Journal:  Drugs       Date:  1999       Impact factor: 9.546

4.  Pharmacokinetics of vinorelbine in man.

Authors:  P Marquet; G Lachatre; J Debord; B Eichler; F Bonnaud; G Nicot
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 5.  Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.

Authors:  K L Goa; D Faulds
Journal:  Drugs Aging       Date:  1994-09       Impact factor: 3.923

6.  Vinorelbine Delivery and Efficacy in the MDA-MB-231BR Preclinical Model of Brain Metastases of Breast Cancer.

Authors:  Ramakrishna Samala; Helen R Thorsheim; Satyanarayana Goda; Kunal Taskar; Brunilde Gril; Patricia S Steeg; Quentin R Smith
Journal:  Pharm Res       Date:  2016-08-19       Impact factor: 4.200

7.  Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinorelbine in mice as determined by high performance liquid chromatography.

Authors:  O van Tellingen; A V Kuijpers; J H Beijnen; W J Nooijen; A Bult
Journal:  Invest New Drugs       Date:  1993 May-Aug       Impact factor: 3.850

8.  Pulmonary distribution of vinorelbine in patients with non-small-cell lung cancer.

Authors:  D Levêque; E Quoix; P Dumont; G Massard; J G Hentz; A Charloux; F Jehl
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

9.  Vinorelbine high-affinity binding to human platelets and lymphocytes: distribution in human blood.

Authors:  S Urien; F Brée; F Breillout; G Bastian; A Krikorian; J P Tillement
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

Review 10.  Vinorelbine and the topoisomerase 1 inhibitors: current and potential roles in breast cancer chemotherapy.

Authors:  S O'Reilly; M J Kennedy; E K Rowinsky; R C Donehower
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.